Article Details
Retrieved on: 2021-08-10 10:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Looking beyond our neuroscience program, our Phase 1/2b study of BXCL701 for castrate resistant prostate cancer is advancing well, with additional ...
Article found on: finance.yahoo.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here